Clinical TrialsThe FDA approved the Investigational New Drug application for a Phase IIb imaging trial of RAD 101 in brain metastases, marking a significant regulatory milestone.
Market ExpansionRadiopharm announced the launch of American Depository Shares, which will be traded in the U.S. over-the-counter market as RADTY, with plans for a secondary listing on Nasdaq.
Therapeutic PipelineRadiopharm Theranostics has focused its therapeutic pipeline on biologically validated targets that have seen limited or no use in radiopharmaceuticals, which is designed to de-risk development and limit competition.